3rd Quarter - Report
FOLEY HOAG LLP for ELI LILLY AND COMPANY
Firm
Client
Income
$75,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.